{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:10:00Z","timestamp":1747203000503,"version":"3.40.5"},"reference-count":24,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,9]]},"DOI":"10.20945\/2359-3997000000296","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T19:10:38Z","timestamp":1603307438000},"source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and clinical characteristics of X-linked hypophosphatemia in Paran\u00e1, southern Brazil"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9908-4907","authenticated-orcid":false,"given":"Carolina Aguiar","family":"Moreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4091-6120","authenticated-orcid":false,"given":"Tatiana M. R. Lemos","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5610-9564","authenticated-orcid":false,"given":"Julia Vieira Oberger","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6719-6509","authenticated-orcid":false,"given":"Lucimary","family":"Sylvestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7289-5873","authenticated-orcid":false,"given":"Ana Cristina R.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3060-7351","authenticated-orcid":false,"given":"Eliane M. C. P.","family":"Maluf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0555-0880","authenticated-orcid":false,"given":"Vict\u00f3ria Z. C.","family":"Borba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"issue":"7","key":"key20201021151032_B1","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia [published correction appears in J Bone Miner Res. 2015 Feb;30(2):394]","volume":"26","author":"Carpenter","year":"2011","unstructured":"1. Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician's guide to X-linked hypophosphatemia [published correction appears in J Bone Miner Res. 2015 Feb;30(2):394]. J Bone Miner Res. 2011;26(7):1381-8.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"key20201021151032_B2","first-page":"529","article-title":"Rickets resistant to vitamin D therapy","volume":"54","author":"Albright","year":"1937","unstructured":"2. Albright F, Butler AM, Bloomberg E. Rickets resistant to vitamin D therapy. Am J Dis Child. 1937;54(3):529-47.","journal-title":"Am J Dis Child"},{"issue":"8","key":"key20201021151032_B3","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1210\/jcem.86.8.7761","article-title":"Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets","volume":"86","author":"Holm","year":"2001","unstructured":"3. Holm IA, Nelson AE, Robinson BG, Mason RS, Marsh DJ, Cowell CT, et al. Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab. 2001;86(8):3889-99.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20201021151032_B4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1523-1755.2000.00807.x","article-title":"PHEX gene and hypophosphatemia","volume":"57","author":"Drezner","year":"2000","unstructured":"4. Drezner MK. PHEX gene and hypophosphatemia. Kidney Int. 2000;57(1):9-18.","journal-title":"Kidney Int"},{"issue":"3","key":"key20201021151032_B5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","unstructured":"5. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res. 2004;19(3):429-35.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"key20201021151032_B6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","unstructured":"6. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004;113(4):561-8.","journal-title":"J Clin Invest"},{"issue":"6","key":"key20201021151032_B7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00005792-198911000-00002","article-title":"X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults","volume":"68","author":"Reid","year":"1989","unstructured":"7. Reid IR, Hardy DC, Murphy WA, Teitelbaum SL, Bergfeld MA, Whyte MP. X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults. Medicine (Baltimore). 1989;68(6):336-52.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"key20201021151032_B8","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10545-018-0147-6","article-title":"Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations","volume":"41","author":"Chesher","year":"2018","unstructured":"8. Chesher D, Oddy M, Darbar U, Sayal P, Casey A, Ryan A, et al. Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations. J Inherit Metab Dis. 2018;41(5):865-76.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"key20201021151032_B9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1148\/radiology.171.2.2539609","article-title":"X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features","volume":"171","author":"Hardy","year":"1989","unstructured":"9. Hardy DC, Murphy WA, Siegel BA, Reid IR, Whyte MP. X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features. Radiology. 1989;171(2):403-14.","journal-title":"Radiology"},{"issue":"3","key":"key20201021151032_B10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/EJE-15-0661","article-title":"Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms","volume":"174","author":"Che","year":"2016","unstructured":"10. Che H, Roux C, Etcheto A, Rothenbuhler A, Kamenicky P, Linglart A, et al. Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms. Eur J Endocrinol. 2016;174(3):325-33.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"key20201021151032_B11","doi-asserted-by":"crossref","first-page":"E1492","DOI":"10.1210\/jc.2012-1336","article-title":"Abnormalities in muscle density and muscle function in hypophosphatemic rickets","volume":"97","author":"Veilleux","year":"2012","unstructured":"11. Veilleux LN, Cheung M, Ben Amor M, Rauch F. Abnormalities in muscle density and muscle function in hypophosphatemic rickets. J Clin Endocrinol Metab. 2012;97(8):E1492-8.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20201021151032_B12","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab Therapy in Children with X-Linked Hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","unstructured":"12. Carpenter TO, Whyte MP, Imel EA, Boot AM, Hogler W, Linglart A, et al. Burosumab Therapy in Children with X-Linked Hypophosphatemia. N Engl J Med. 2018;378:1987-98.","journal-title":"N Engl J Med"},{"issue":"8","key":"key20201021151032_B13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis","volume":"33","author":"Insogna","year":"2018","unstructured":"13. Insogna KL, Briot K, Imel EA, Kamenick\u00fd P, Ruppe MD, Portale AA, et al. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis. J Bone Miner Res. 2018;33(8):1383-93.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"key20201021151032_B14","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1210\/js.2018-00338","article-title":"Nephrocalcinosis and Nephrolithiasis in X-Linked Hypophosphatemic Rickets: Diagnostic Imaging and Risk Factors","volume":"3","author":"Colares","year":"2019","unstructured":"14. Colares Neto GP, Ide Yamauchi F, Hueb Baroni R, Bianchi MA, Gomes AC, Chammas MC, et al. Nephrocalcinosis and Nephrolithiasis in X-Linked Hypophosphatemic Rickets: Diagnostic Imaging and Risk Factors. J Endocr Soc. 2019;3(5):1053-61.","journal-title":"J Endocr Soc"},{"issue":"3","key":"key20201021151032_B15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-08-0818","article-title":"Incidence and prevalence of nutritional and hereditary rickets in southern Denmark","volume":"160","author":"Beck-Nielsen","year":"2009","unstructured":"15. Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK. Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol. 2009;160(3):491-7.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"key20201021151032_B16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/EJE-15-0515","article-title":"Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications","volume":"174","author":"Rafaelsen","year":"2016","unstructured":"16. Rafaelsen S, Johansson S, R\u00e6der H, Bjerknes R. Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications. Eur J Endocrinol. 2016;174(2):125-36.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"key20201021151032_B17","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1507\/endocrj.EJ15-0275","article-title":"Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment","volume":"62","author":"Endo","year":"2015","unstructured":"17. Endo I, Fukumoto S, Ozono K, Namba N, Inoue D, Okazaki R, et al. Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment. Endocr J. 2015;62(9):811-6.","journal-title":"Endocr J"},{"journal-title":"IBGE Journal","author":"Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE)","key":"key20201021151032_B18","unstructured":"18. Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE). IBGE Journal. Available from: https:\/\/www.ibge.gov.br\/cidades-e-estados\/pr\/. Access on: Dec. 2018."},{"issue":"8","key":"key20201021151032_B19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00431-008-0864-1","article-title":"Nutritional rickets in Denmark: a retrospective review of children's medical records from 1985 to 2005","volume":"168","author":"Beck-Nielsen","year":"2009","unstructured":"19. Beck-Nielsen SS, Jensen TK, Gram J, Brixen K, Brock-Jacobsen B. Nutritional rickets in Denmark: a retrospective review of children's medical records from 1985 to 2005. Eur J Pediatr. 2009;168(8):941-9.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"key20201021151032_B20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13052-019-0654-6","article-title":"X-linked hypophosphatemic rickets: an Italian experts\u2019 opinion survey","volume":"45","author":"Emma","year":"2019","unstructured":"20. Emma F, Cappa M, Antoniazzi F, Bianchi ML, Chiodini I, Vainicher CE, et al. X-linked hypophosphatemic rickets: an Italian experts\u2019 opinion survey. Ital J Pediatr. 2019;45(1):67.","journal-title":"Ital J Pediatr"},{"issue":"26","key":"key20201021151032_B21","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1056\/NEJM199112263252604","article-title":"Effects of therapy in X-linked hypophosphatemic rickets","volume":"325","author":"Verge","year":"1991","unstructured":"21. Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M. Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med. 1991;325(26):1843-8.","journal-title":"N Engl J Med"},{"issue":"2","key":"key20201021151032_B22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00467-005-2077-4","article-title":"Hypophosphatemic rickets: results of a long-term follow-up","volume":"21","author":"Vaisbich","year":"2006","unstructured":"22. Vaisbich MH, Koch VH. Hypophosphatemic rickets: results of a long-term follow-up. Pediatr Nephrol. 2006;21(2):230-4.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"key20201021151032_B23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4111\/kju.2010.51.1.54","article-title":"Phosphaturia as a promising predictor of recurrent stone formation in patients with urolithiasis","volume":"51","author":"Ha","year":"2010","unstructured":"23. Ha YS, Tchey DU, Kang HW, Kim YJ, Yun SJ, Lee SC, et al. Phosphaturia as a promising predictor of recurrent stone formation in patients with urolithiasis. Korean J Urol. 2010;51(1):54-9.","journal-title":"Korean J Urol"},{"issue":"7","key":"key20201021151032_B24","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/js.2018-00365","article-title":"The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey","volume":"3","author":"Skrinar","year":"2019","unstructured":"24. Skrinar A, Dvorak-Ewell M, Evins A, Macica C, Linglart A, Imel EA, et al. The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey. J Endocr Soc. 2019;3(7):1321-34.","journal-title":"J Endocr Soc"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T19:10:54Z","timestamp":1603307454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972020005007205&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":24,"alternative-id":["10.20945\/2359-3997000000296"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000296","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"type":"print","value":"2359-3997"},{"type":"electronic","value":"2359-4292"}],"subject":[],"published":{"date-parts":[[2020,10,9]]}}}